We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Greiner Bio-One to Serve Spain and Portugal through Distribution Subsidiaries

By LabMedica International staff writers
Posted on 28 Mar 2017
Print article
Greiner Bio-One has acquired its long-standing distribution partners, VacuetteEspaña and Vacuette Portugal, which will now allow the medical technology company to serve its customers in Spain and Portugal directly through its own distribution subsidiaries.

Greiner Bio-One, a part of the Greiner Group, specializes in the development, production and distribution of high-quality plastic products for laboratory use. The company is a technology partner for hospitals, laboratories, universities, research institutes, the diagnostic and pharmaceutical industry and biotechnology.

For over 20 years, the Greiner Group has worked with VacuetteEspaña, S.A. and Vacuette Portugal Importação e Exportação de Material Hospitalar, S.A., both of which were previously exclusive distributors for Greiner Bio-One International on the Iberian Peninsula. Towards the end of February 2017, Greiner Bio-One entered into official acquisition agreements with both of its distribution partners that came into effect on March 1, 2017. The two subsidiaries in Madrid and Porto will now continue to supply directly to their customers in both the markets.

“Having our own local subsidiaries will bring us closer to our customers and enable us to cater to our markets even more effectively at an international level. The acquisition of VacuetteEspaña and Vacuette Portugal is another key step in our globalization strategy,” said Axel Kühner, Chairman of the Management Board of the Greiner Group.

“Following the establishment of our own distribution subsidiaries in Turkey and Italy last year, the new Greiner Bio-One sites in Spain and Portugal are the next step in systematic implementation of our distribution strategy in Europe,” added Rainer Perneker, CEO of Greiner Bio-One International.

“By attaining greater proximity to customers, we aim to develop the two markets on the Iberian Peninsula in an even more targeted way. The acquisitions mark the continuation of our growth over many years and allow us to step up services and customer care at the local level,” said Manfred Buchberger, CEO of Greiner Bio-One Preanalytics.

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
AST Cards
Antimicrobial Susceptibility Testing Cards
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.